Cargando…

MD-2 as a possible therapeutic target for atherosclerosis

Detalles Bibliográficos
Autores principales:	Chen, Shuang, Crother, Timothy R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217989/ https://www.ncbi.nlm.nih.gov/pubmed/32388463 http://dx.doi.org/10.1016/j.ebiom.2020.102760

Ejemplares similares

Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target?
por: Sutton, Greg, et al.
Publicado: (2019)

The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits
por: Mohanta, Sarajo Kumar, et al.
Publicado: (2022)

MiR-214-3p, a novel possible therapeutic target for the pathogenesis of osteoarthritis
por: Fioravanti, Antonella, et al.
Publicado: (2021)

Saul Hertz, MD, and the birth of radionuclide therapy
por: Fahey, Frederic H., et al.
Publicado: (2017)

Emil “Tom” Frei III, MD (1924-2013)
por: Bose, Chinmoy K.
Publicado: (2014)

Paul Greig, MD – Professor of Surgery, University of Toronto
por: Dixon, Elijah, et al.
Publicado: (2023)

MD2 AMP(K)s up the link between lipid accumulation and inflammation in NAFLD
por: Heldens, Anneleen, et al.
Publicado: (2022)

Is atherosclerosis an autoimmune disease?
por: Matsuura, Eiji, et al.
Publicado: (2014)

In Memoriam of John T. Trojanowski, MD, PhD 1946-2022
por: Zheng, Hui, et al.
Publicado: (2022)

Alexander Alexandrovich Potapov, MD, PhD, 1948–2021
por: Kato, Yoko
Publicado: (2021)

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer
por: Andersen, Mads Hald, et al.
Publicado: (2006)

Moving miRNAs to therapeutic targets in colorectal cancer
por: McGregor, Mark, et al.
Publicado: (2019)

Intestinal Microbiome and Atherosclerosis
por: Spence, J. David
Publicado: (2016)

Intestinal Microbiome and Atherosclerosis – Authors' Reply
por: Chen, Lin, et al.
Publicado: (2016)

Dicarbonyl Stress and Atherosclerosis: Is It All RAGE?
por: Muniyappa, Ranganath, et al.
Publicado: (2014)

Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
por: Davidson, Michael H.
Publicado: (2015)

The Road to Toxin-Targeted Therapeutic Antibodies
por: Kozel, Thomas R.
Publicado: (2014)

Plasmacytoid dendritic cells and their therapeutic activity in cancer
por: Pinto, Aldo, et al.
Publicado: (2012)

LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson’s Disease
por: Wang, Youcui, et al.
Publicado: (2021)

Possible new therapeutic approach for obesity-related diseases: Role of adiponectin receptor agonists
por: Lee, Chien-Hsing, et al.
Publicado: (2015)

In memoriam: Celso-Ramon Garcia, M.D. (1922–2004), reproductive medicine visionary
por: Strauss, Jerome F, et al.
Publicado: (2005)

BAD: a good therapeutic target?
por: Motoyama, Andrea B, et al.
Publicado: (2003)

Role of TRIB3 in Diabetic and Overnutrition-Induced Atherosclerosis
por: Sowers, James R.
Publicado: (2012)

Inflammation as a Therapeutic Target in Atherosclerosis
por: Nguyen, Mau T, et al.
Publicado: (2019)

Remembering George L. Wied, M.D., February 7, 1921-July 25, 2004
por: Rosenthal, Dorothy L
Publicado: (2005)

Targeting oncogenic SOX2 in human cancer cells: therapeutic application
por: Zhang, Shizhen, et al.
Publicado: (2019)

Is targeting circulating T blood cells a therapeutic option for vitiligo?
por: Matos, T.R.
Publicado: (2020)

Purine metabolism promotes radioresistance and is a therapeutic target in glioblastoma
por: Zhou, Weihua, et al.
Publicado: (2020)

New targets for new therapeutic approaches
por: François, Bruno
Publicado: (2014)

Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis
por: Chen, Zhongxiu, et al.
Publicado: (2017)

Adiponectin Paradox as a Therapeutic Target in Alzheimer’s Disease
por: Waragai, Masaaki, et al.
Publicado: (2020)

Targeting gut microbiome, is it always a therapeutic option?
por: Rodríguez-Nogales, Alba, et al.
Publicado: (2020)

Interleukin-18: a therapeutic target in rheumatoid arthritis?
por: McInnes, Iain B, et al.
Publicado: (2005)

B cells as a therapeutic target in autoimmune disease
por: Goronzy, Jörg J, et al.
Publicado: (2003)

PERK: a novel therapeutic target for neurodegenerative diseases?
por: Ma, Tao, et al.
Publicado: (2014)

Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis
por: Li, Jing, et al.
Publicado: (2022)

Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19)
por: Medvegy, Mihály, et al.
Publicado: (2021)

Targeting hypoxia in tumor: a new promising therapeutic strategy
por: Bosco, Maria Carla, et al.
Publicado: (2020)

Chromatin state profiling reveals PRC2 inhibition as a therapeutic target in NRAS–mutant melanoma
por: Terranova, Christopher J.
Publicado: (2021)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3maigs1bun8094mlqbnnk724ou